While neurofibrillary tangles (NFTs) characterize tauopathies and are not correlative of synucleinopathies, recent studies suggest that intermediate forms of tau—tau oligomers—that form prior to or independently of NFTs, are the true toxic species in disease and the optimum targets for anti-tau therapies [30–35]. Here, MAPT is linked to synucleinopathy.